Cocrystal Pharma Inc Sustainability Reports
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that discovers and develops novel antiviral therapeutics. The company employs a unique structure-based drug discovery technology platform to create therapies targeting viral replication processes.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300QCJ6RBUJKI7S66
FIGI: BBG001T107W2
5 reports from 2016 to 2022
